-The Times of India MUMBAI: The government has banned three popular medicines-the widely prescribed anti-diabetes drug pioglitazone, painkiller analgin and anti-depressant deanxit-in the wake of health risks associated with them. While it's believed that pioglitazone can cause heart failure and increases the risk of bladder cancer, analgin has been discarded the world over on grounds of patient safety. Deanxit, on the other hand is a harmful combination, which has been long...

-The Economic Times NEW DELHI: Top-selling blood pressure drugs and antibiotics could become a lot cheaper as the government plans to notify price caps for 51 essential drugs early next week under a new drug price control order that was enforced last month. Under this second lot of notifications by the National Pharma Pricing Authority, the brands selling the most expensive antibiotics would have to cut their prices by 30-60%. For instance, the...

-The Business Standard Data also show that several other leading domestic Pharma companies have recalled their products from the US Frequent drug recalls, warning letters and import alerts from the US in the recent past have turned into a major concern for the Indian pharmaceutical industry and investors. While Ranbaxy Laboratories recently pleaded guilty before the US authorities for its wrongdoings in the past, the crackdown on the drug companies seems to...

-The New York Times CAMBRIDGE, Mass. - MODERN India is, in many ways, a success. Its claim to be the world's largest democracy is not hollow. Its media is vibrant and free; Indians buy more newspapers every day than any other nation. Since independence in 1947, life expectancy at birth has more than doubled, to 66 years from 32, and per-capita income (adjusted for inflation) has grown fivefold. In recent decades,...

-Newsclick.in A few weeks back Fortune magazine and CNN carried a long online blog titled ‘Dirty Medicine' by Dinesh Thakur, a former employ of Ranbaxy, where he recounts how he came across several procedural and other lapses in the company's manufacturing facilities. Since then the Fortune blog has become one of the most widely circulated and commented upon business stories in the world. The story received attention as it came in the...